#ITI#Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5#FTI#
#IRE#Protective immunity to avian influenza (AI) virus can be elicited in chickens by in ovo or intramuscular vaccination with replication-competent adenovirus (RCA)-free human recombinant adenovirus serotype 5 (Ad5) encoding AI virus H5 (AdTW68.H5) or H7 (AdCN94.H7) hemagglutinins. We evaluated bivalent in ovo vaccination with AdTW68.H5 and AdCN94.H7 and determined that vaccinated chickens developed robust hemagglutination inhibition (HI) antibody levels to both H5 and H7 AI strains. Additionally, we evaluated immune responses of 1-day-old chickens vaccinated via spray with AdCN94.H7. These birds showed increased immunoglobulin A responses in lachrymal fluids and increased interleukin-6 expression in Harderian gland-derived lymphocytes. However, specific HI antibodies were not detected in the sera of these birds. Because pigs might play a role as a "mixing vessel" for the generation of pandemic influenza viruses we explored the use of RCA-free adenovirus technology to immunize pigs against AI virus. Weanling piglets vaccinated intramuscularly with a single dose of RCA-free AdTW68.H5 developed strong systemic antibody responses 3 wk postvaccination. Intranasal application of AdTW68.H5 in piglets resulted in reduced vaccine coverage, i.e., 33% of pigs (2/6) developed an antibody response, but serum antibody levels in those successfully immunized animals were similar to intramuscularly vaccinated animals. Â© 2010 American Association of Avian Pathologists.#FRE#
#IPC#Adenovirus; Avian influenza; Chickens; Pigs; Recombinant; Vaccination#FPC#
#IRF#Albini B., Wick G., Rose E., Orlans E., Immunoglobulin production in chicken Harderian glands, Int. Arch. Allergy Appl. Immunol., 47, pp. 23-34, (1974); 
Bienenstock J., Gauldie J., Perey D.Y., Synthesis of IgG, IgA, IgM by chicken tissues: Immunofluorescent and 14C amino acid incorporation studies, J. Immunol., 111, pp. 1112-1118, (1973); 
Burns R.B., Specific antibody production against a soluble antigen in the Harderian gland of the domestic fowl, Clin. Exp. Immunol., 26, pp. 371-374, (1976); 
Capua I., Marangon S., Dalla Pozza M., Santucci U., Vaccination for avian influenza in Italy, Vet. Rec., 147, (2000); 
Choi Y.K., Nguyen T.D., Ozaki H., Webby R.J., Puthavathana P., Buranathal C., Chaisingh A., Auewarakul P., Hanh N.T., Ma S.K., Hui P.Y., Guan Y., Peiris J.S., Webster R.G., Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004, J. Virol., 79, pp. 10821-10825, (2005); 
Crawley J.F., Present status of infectious bronchitis immunization, Proc. Am. Vet. Med. Assoc., pp. 343-350, (1955); 
Davelaar F.G., Noordizij A., Donk Der Van J.A., A study on the synthesis and secretion of immunoglobulins by the Harderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1-day-old, Avian Pathol, 11, pp. 63-79, (1982); 
Ginkel F.W.V., Tang D.C., Gulley S.L., Toro H., Induction of mucosal immunity in the avian Harderian gland with a replication deficient Ad-5 vector expressing avian influenza H5 hemagglutinin, Develop. Comp. Immunol., 33, pp. 28-34, (2009); 
He T.C., Zhou S., Da Costa L.T., Yu J., Kinzler K.W., Vogelstein B., A simplified system for generating recombinant adenoviruses, Proc. Natl. Acad. Sci. U. S. A., 95, pp. 2509-2514, (1998); 
Hilleman M.R., Realities and enigmas of human viral influenza: Pathogenesis, epidemiology and control, Vaccine, 20, pp. 3068-3087, (2002); 
Jungherr E.L., Luginbuhl R.E., Report on poultry respiratory disease control program for 1949 and suggestions for 1950, Proc. 22nd Annual Conference of Laboratory Workers Pullorum Disease Control, (1949); 
Konz J.O., Livingood R.C., Bett A.J., Goerke A.R., Laska M.E., Sagar S.L., Serotype specificity of adenovirus purification using anionexchange chromatography, Hum. Gene Ther., 16, pp. 1346-1353, (2005); 
Lee C.W., Senne D.A., Suarez D.L., Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza, Vaccine, 22, pp. 3175-3181, (2004); 
Lewis J.A., Brown E.L., Duncan P.A., Approaches to the release of a master cell bank of PER.C6 cells; A novel cell substrate for the manufacture of human vaccines, Dev. Biol. (Basel), 123, pp. 165-176, (2006); 
Lipatov A.S., Kwon Y.K., Sarmento L.V., Lager K.M., Spackman E., Suarez D.L., Swayne D.E., Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses, PLoS Pathog, 4, (2008); 
Lochmuller H., Jani A., Huard J., Prescott S., Simoneau M., Massie B., Karpati G., Acsadi G., Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells, Hum. Gene Ther., 5, pp. 1485-1491, (1994); 
Ludwig S., Stitz L., Planz O., Van H., Fitch W., Scholtissek C., European swine virus as a possible source for the next influenza pandemic?, Virology, 212, pp. 555-561, (1995); 
Park M.S., Steel J., Garcia-Sastre A., Swayne D., Palese P., Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease, Proc. Natl. Acad. Sci. U. S. A., 103, pp. 8203-8208, (2006); 
Sharma J.M., Burmester B.R., Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus, Avian Dis, 26, pp. 134-149, (1982); 
Shi Z., Zeng M., Yang G., Siegel F., Cain L.J., Van Kampen K.R., Elmets C.A., Tang D.C., Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines, J. Virol., 75, pp. 11474-11482, (2001); 
Suarez D.L., Schultz-Cherry S., The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model, Avian Dis, 44, pp. 861-868, (2000); 
Swayne D.E., Vaccines for List A poultry diseases: Emphasis on avian influenza, Dev. Biol. (Basel), 114, pp. 201-212, (2003); 
Swayne D.E., Beck J.R., Kinney N., Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens pre-immunized with a fowl pox vaccine, Avian Dis, 44, pp. 132-137, (2000); 
Swayne D.E., Senne D.A., Beard C.W., Influenza, Isolation and Identification of Avian Pathogens, pp. 150-155, (1998); 
Toro H., Lavaud P., Vallejos P., Ferreira A., Transfer of IgG from serum to lacrimal fluid in chickens, Avian Dis, 37, pp. 60-66, (1993); 
Toro H., Tang D.C., Suarez D.L., Sylte M.J., Pfeiffer J., Van Kampen K.R., Protective avian influenza in ovo vaccination with nonreplicating human adenovirus vector, Vaccine, 25, pp. 2886-2891, (2007); 
Toro H., Tang D.C., Suarez D.L., Zhang J., Shi Z., Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine, Vaccine, 26, pp. 2640-2646, (2008); 
Toro H., Van Santen V.L., Li L., Lockaby S.B., Van Santen E., Hoerr F.J., Epidemiological and experimental evidence for immunodeficiency affecting avian infectious bronchitis, Avian Pathol, 35, pp. 1-10, (2006); 
Ungchusak K., Auewarakul P., Dowell S.F., Kitphati R., Auwanit W., Puthavathana P., Uiprasertkul M., Boonnak K., Pittayawonganon C., Cox N.J., Zaki S.R., Thawatsupha P., Chittaganpitch M., Khontong R., Simmerman J.M., Chunsutthiwat S., Probable person-toperson transmission of avian influenza A (H5N1), N. Engl. J. Med., 352, pp. 333-340, (2005); 
Van Ginkel F.W., Liu C.-J., Simecka J.W., Dong J.-Y., Greenway T., Frizzell R.A., Kiyono H., McGhee J.R., Pascual D.W., Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and b-galactosidase, Hum. Gene Ther., 6, pp. 895-903, (1995); 
Van Reeth K., Avian and swine influenza viruses: Our current understanding of the zoonotic risk, Vet. Res., 38, pp. 243-260, (2007); 
Wakenell P.S., Bryan T., Schaeffer J., Avakian A., Williams C., Whitfill C., Effect of in ovo vaccine delivery route on herpesvirus of turkeys/ SB-1 efficacy and viremia, Avian Dis, 46, pp. 274-280, (2002); 
Wesley R.D., Lager K.M., Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus, Am. J. Vet. Res., 66, pp. 1943-1947, (2005); 
Wesley R.D., Lager K.M., Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus, Vet. Microbiol., 118, pp. 67-75, (2006); 
Wesley R.D., Tang M., Lager K.M., Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus, Vaccine, 22, pp. 3427-3434, (2004); 
Recommendations of the OIE/ FAO International Scientific Conference on Avian Influenza [Internet]; 
Zhu J., Grace M., Casale J., Chang A.T., Musco M.L., Bordens R., Greenberg R., Schaefer E., Indelicato S.R., Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector, Hum. Gene Ther., 10, pp. 113-121, (1999)#FRF#
